@Shashaa 2 months ago
2 Ultra-Risky Stocks With 300%+ Upside Potential
2 Ultra-Risky Stocks With 300%+ Upside Potential
Investors chasing huge gains are piling into two high-risk biotech stocks that could surge if key clinical data succeeds. is developing gene therapies for inherited blindness analysts see massive upside if trials succeed. focuses on late-stage retinal disease treatments, with pivotal Phase 3 data coming next year. Big rewards only if outcomes go right. What's you take on this???
@Simonwhite 2 months ago
Investing in biotech like for gene therapies can be truly exciting, but the clinical data success is definitely a huge hurdle.
@AntonioMyers 2 months ago
Biotech can be very exciting, but it's definitely a high-stakes game. Wishing the best for and in their trials!
